David Hallal, Scholar Rock CEO, joins ‘Fast Money’ to talk its recent drug study results that found its drug taken in combination with Zepbound helped prevent muscle loss.
Trending
- Whispers of a new world order
- European markets on Weds June 25: Stoxx, FTSE, DAX, CAC
- Celebrate the truce — but it doesn’t promise peace
- Europe must wake up amid complicated U.S. relations
- The U.K.’s pension shake-up is facing pushback
- Japan’s inflation above target for over 3 years, but where is BOJ?
- A gay anti-bullying ad by Hilary Duff became a cult classic
- Donald Trump, Israel Iran, ceasefire
Scholar Rock CEO on its drug that could preserve muscle in weight-loss drug users
